Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: FNS who wrote (643)	4/9/1998 11:55:00 AM
From: PawPr	Read Replies (2) \| Respond to of 965

I've continued to follow CNTO although, as I've previously indicated, I sold my entire position on 3/30. I'm hoping to get back in at an attractive price sometime in the next month. I agree that 40 is a critical support level but quite frankly I do not like the way the stock has been acting lately. There may be some concern about an upcoming FDA meeting on Merck's Accustat, but I'd be surprised if the meeting was held tomorrow given the fact that it's a holiday weekend. The biggie for CNTO is Avakine, which I think will be approved ( initially for Crohn's Disease ) but the market is looking for much wider use later on so any bad news next month could really knock the stuffing out of the stock price. BT